Sort   by:  
 Page size 
Liraglutide, a GLP-1 receptor agonist approved for diabetes and obesity, shows promise in treating NAFLD, the most prevalent chronic liver disease globally. Despite its therapeutic potential, the systematic molecular regulations underlying Liraglutide effects on NAFLD remain underexplored, indicatin...
ORGANISM(S): Mus musculus (Mouse) 
2025-12-15 | PXD055468 | Pride
Proteomic and metabolomic characterization of migraine patient plasma with acupuncture intervention
ORGANISM(S): Homo Sapiens 
Sort   by:  
 Page size